Literature DB >> 31292539

Calming inflammation to prevent stroke damage.

Alexandra Flemming1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31292539     DOI： 10.1038/s41577-019-0197-5

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  1 in total

1.  Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity.

Authors:  Qingkun Liu; Emily M Johnson; Rachel K Lam; Qian Wang; Hong Bo Ye; Edward N Wilson; Paras S Minhas; Ling Liu; Michelle S Swarovski; Stephanie Tran; Jing Wang; Swapnil S Mehta; Xi Yang; Joshua D Rabinowitz; Samuel S Yang; Mehrdad Shamloo; Christoph Mueller; Michelle L James; Katrin I Andreasson
Journal:  Nat Immunol       Date:  2019-07-01       Impact factor: 25.606
  1 in total
  4 in total

1.  Long Noncoding RNA Fos Downstream Transcript Is Developmentally Dispensable but Vital for Shaping the Poststroke Functional Outcome.

Authors:  Suresh L Mehta; Anil K Chokkalla; TaeHee Kim; Saivenkateshkomal Bathula; Bharath Chelluboina; Kahlilia C Morris-Blanco; Aleah Holmes; Anik Banerjee; Anjali Chauhan; Juneyoung Lee; Venugopal R Venna; Louise D McCullough; Raghu Vemuganti
Journal:  Stroke       Date:  2021-05-04       Impact factor: 10.170

Review 2.  Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives.

Authors:  Tianqi Tu; Zhenghong Peng; Jian Ren; Hongqi Zhang
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

3.  Highly bioactive zeolitic imidazolate framework-8-capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke.

Authors:  Lizhen He; Guanning Huang; Hongxing Liu; Chengcheng Sang; Xinxin Liu; Tianfeng Chen
Journal:  Sci Adv       Date:  2020-03-18       Impact factor: 14.136

4.  The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke.

Authors:  Ruiqing Kang; Marcin Gamdzyk; Cameron Lenahan; Jiping Tang; Sheng Tan; John H Zhang
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.